Pfizer CentreOne

Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.

In this podcast, hear from our global experts Martin Gonzalez, PHD and Katharine Sparhawk as they share exclusive details of Pfizer CentreOne’s sterile injectable capabilities from both a technical expertise and business development point of view. Our experts will explore key topics including emerging sterile injectable trends, the company’s approach to flexibility in capacity planning and emerging trends that are shaping the development of complex biologics like ADCs.

In this application note, Pfizer CentreOne examines key considerations for the development and manufacturing of your unique sterile injectable.

Developing and manufacturing highly potent oral solid dose drugs to respond to increasing demand in the industry requires specialized procedures and expertise.

In this application note, Pfizer CentreOne examines key considerations for the development and manufacturing of your unique sterile injectable.

You can rely on Pfizer CentreOne as your CDMO for high-quality API synthesis, from process development through long-term supply. Our capabilities include complex organic synthesis, fermentation and bioprocessing up to 150,000-liter scale, milling and micronizing, process optimization and scale-up, and process industrialization.

Development of novel small molecule active pharmaceutical ingredients (APIs) is increasingly turned over to outsourced partners who have become the primary drivers of the product’s overall development and go-to-market strategy. With hundreds of potential partners that drug owners can choose from to develop and manufacture small molecule APIs, choosing the best partner can be a challenging task. In this white paper, we explore the importance of purposefully aligning the overall drug development strategy with a partnering strategy. We also review how increasing development of novel drugs are also impacting the industry’s go-to-market efforts, driving new demand for expert small molecule API suppliers. Finally, we consider how small molecule API development projects can be executed by leveraging the experience of embedded contract development and manufacturing (CDMO) partners.

Process development methods & analytical requirements are integral parts of gene therapy manufacturing. This whitepaper explores the analytical and development approaches needed for success.

The diversity & agility of API supply chains is key to ensuring that medicines can be manufactured & delivered to patients; this Ebook explores the path to a secure supply chain.

With the support of our dedicated experts, Pfizer CentreOne can help your product scale up to commercial and reliably deliver your product to your patients under the highest quality standards for which Pfizer stands for.

Specializing in oncology, anti-infective and complex formulations, Pfizer CentreOne provides end to end services from development through to commercial manufacture of sterile dosage forms.

Pfizer CentreOne® is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Visit www.pfizercentreone.com.

Pfizer CentreOne® is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Visit www.pfizercentreone.com.

Pfizer CentreOne® is a global CDMO embedded within Pfizer and specializes in small molecule API synthesis.

A review of the market dynamics and drug development trends driving strategic outsourcing decisions.